Cancer Advisor

By The Medical Advisor Editorial Team | Last Updated: May 2026 Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Cancer treatment is highly individualized. Metabolic interventions can interact with chemotherapy, immunotherapy, or radiation and may cause harm if used improperly. Always consult your oncology team before adding any intervention. Evidence levels vary; many elements discussed remain investigational. Executive Summary Cancer is increasingly understood as more than a genetic disease. Dr. Thomas N. Seyfried , Professor of Biology at Boston College, and a growing body of metabolic oncology researchers propose that dysfunctional cellular energy production — centered on the mitochondria — is a defining and potentially modifiable axis of cancer biology. A 2026 large-scale population study published in Nature Communications demonstrated that machine learning-predicted insulin resistance was associated with increased risk of...

Abstract The metabolic theory of cancer, popularized by Thomas Seyfried, proposes that cancer is fundamentally a disease of mitochondrial dysfunction and altered energy metabolism rather than solely a genetic disorder. Building upon the pioneering work of Otto Warburg, Seyfried argues that many cancer cells depend heavily on glucose fermentation and glutamine metabolism due to impaired oxidative phosphorylation. This article reviews the scientific basis of Seyfried’s metabolic theory, including the Warburg effect, ketogenic metabolic therapy, fasting, mitochondrial dysfunction, hyperbaric oxygen therapy, and emerging concepts involving lipid metabolism, carbon dioxide physiology, and oxidative stress. We also examine criticisms, limitations, and future directions in metabolic oncology research. Introduction Cancer research has traditionally focused on genetic mutations as the primary drivers of tumor development. However, a growing body of research suggests that metabolic dysfunction m...

Authors:  Ilyes Baghli 1 , William Makis 2 , Paul E. Marik 3 , Michael J. Gonzalez 4,5,6 , William B. Grant 7 , Ron Hunninghake 8 , Thomas E. Levy 8 , Homer Lim 9 , Richard Z. Cheng 10 , Igor Bondarenko 11 , Paul Bousquet 12 , Roberto Ortiz 13 , Mignonne Mary 14 , Dominic P. D’Agostino 15 , Pierrick Martinez 16 1  International Society for Orthomolecular Medicine, Toronto, ON, Canada 2  Alberta Health Services, Cross Cancer Institute, Edmonton, AB, Canada 3  Frontline COVID-19 Critical Care Alliance, Washington, DC, USA 4  University of Puerto Rico, Medical Sciences Campus, School of Public Health, San Juan, PR 5  Universidad Central del Caribe, School of Chiropractic, Bayamon, Puerto Rico 6  EDP University, Naturopathic Sciences Program, Hato Rey, Puerto Rico 7  Sunlight, Nutrition, and Health Research Center, San Francisco, CA, USA 8  Riordan Clinic, 3100 North Hillside, Wichita, KS, USA 9  Akesis Holistic Health, Manila, Philippines 1...

Quick Answer The Somatic Mutation Theory (SMT) — the model that has guided oncology since the 1970s — holds that cancer starts with random DNA mutations. The 2005 Cancer Genome Atlas Project largely dismantled that idea: no "founding mutation" was ever found, and mutation patterns varied wildly between and within tumors. The Metabolic Theory of Cancer (MTOC) , developed by Dr. Thomas Seyfried at Boston College from decades of mitochondrial research (Otto Warburg, Peter Pedersen), argues that cancer originates from damaged mitochondria forcing cells into fermentation-based energy production (the Warburg effect), with nuclear mutations arising downstream as a consequence, not a cause. This reframing supports combining standard oncology with ketogenic/calorie-restricted metabolic protocols , repurposed drug combinations (e.g., metformin, statins, mebendazole, doxycycline), and cancer-stem-cell-targeting agents — approaches now backed by published trials such as CUSP9...